14
FEB
2011
Northwest Biotherapeutics To Present At BIO CEO & Investor Conference
Comments : Off
Highlights Include Clinical and Corporate Updates, Striking Long-Term Data, and Lack of Toxicity, Low Cost and Simplicity of DCVax® Therapeutic Vaccines Bethesda, Maryland, February 14, 2011 – Northwest Biotherapeutics (OTC Bulletin Board: NWBO) announced today that its Chair of the Board of Directors, Ms. Linda Powers, will give a corporate presentation at the 13th Annual Biotechnology Industry Organization’s BIO CEO &... Read More